000 01203 a2200337 4500
005 20250517123450.0
264 0 _c20171212
008 201712s 0 0 eng d
022 _a1520-6017
024 7 _a10.1016/j.xphs.2016.09.016
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTrasi, Niraj S
245 0 0 _aNon-Sink Dissolution Behavior and Solubility Limit of Commercial Tacrolimus Amorphous Formulations.
_h[electronic resource]
260 _bJournal of pharmaceutical sciences
_c01 2017
300 _a264-272 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aCapsules
650 0 4 _aCrystallization
650 0 4 _aExcipients
_xchemistry
650 0 4 _aImmunosuppressive Agents
_xchemistry
650 0 4 _aPowder Diffraction
650 0 4 _aSolubility
650 0 4 _aTacrolimus
_xchemistry
650 0 4 _aX-Ray Diffraction
700 1 _aPurohit, Hitesh S
700 1 _aWen, Hong
700 1 _aSun, Dajun D
700 1 _aTaylor, Lynne S
773 0 _tJournal of pharmaceutical sciences
_gvol. 106
_gno. 1
_gp. 264-272
856 4 0 _uhttps://doi.org/10.1016/j.xphs.2016.09.016
_zAvailable from publisher's website
999 _c26579722
_d26579722